CBD and Huntington's disease
Huntington's disease affects 5 in 100,000 people. Although rare and little known, this neurodegenerative disease generally affects people aged 35 to 45 and is caused by the mutation of a protein that damages nerve cells.
Of genetic origin, Huntington's disease has, to date, no cure. Fortunately, a lot of research has enabled patients to improve their living environment or even delay the harm caused by the disease.
Among the most popular therapeutic alternatives is CBD. The University of Cordoba (UCO) in collaboration with the Complutense University of Madrid and the Cordovan company VivaCelle Biotechnology have, in fact, highlighted the neuroprotective effect of cannabinoids in Huntington's disease. In addition to improving the symptoms of the disease, the active compound in CBD, known as cannabigerol, makes drug treatments more effective.
And for good reason, it exerts an anti-inflammatory and neuroprotective action, by repairing the affected neurons. Furthermore, it has been shown that CBD optimizes the antioxidant capacities of neurons, while remaining reliable and tolerable, even at a more or less substantial dose.
Whether it's Parkinson's, Alzheimer's or Huntington's disease… CBD helps relieve neurodegenerative diseases by repairing, protecting and cleaning nerve cells. It protects nerve cells from the appearance of senile plaques and promotes the renewal of neurons. Whether cell degeneration is linked to age, trauma, genetics or any other reason, CBD is thus a natural therapeutic resource of choice, accessible to all.